Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.
about
Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbitsEmerging pharmacotherapies for diabetic macular edema.Topical nepafenac in treatment of acute central serous chorioretinopathy.NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway.The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatmentOcular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients.Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single siteComparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study.The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production.Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population.Nonsteroidal anti-inflammatory drugs for retinal disease.Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial.Topical ocular delivery of NSAIDs.Eyelid excoriation and erythema with nepafenac eye drop.Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspensionTreatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%.Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgeryTopical nonsteroidal anti-inflammatory drugs for macular edema.Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.Efficacy and vitreous levels of topical NSAIDs.Cataract surgery and nonsteroidal antiinflammatory drugs.Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components.Amfenac increases the radiosensitivity of uveal melanoma cell lines.Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients.The effects of nepafenac and amfenac on retinal angiogenesis.Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.Intracameral Use of Nepafenac: Safety and Efficacy Study.A Case of Allergic Urticaria After Ophthalmic Nepafenac Use.Analgesics and AntipyreticsEmerging pharmacotherapies for diabetic macular edema
P2860
Q28538492-AAC8C013-F0AC-4357-B02E-57A0B9930EE0Q33304852-1DF54D4C-D8C0-44BF-919A-8D2C8B348ABAQ33597082-EF825391-D3B5-46BC-B9D3-3A204FE5FAC6Q33944298-BAD633EA-23FE-4F54-86F0-F1BB2386B5FDQ34605896-109A2647-4BAD-44B8-A23B-D66194205864Q34806191-ED7E5328-8778-46AB-9C2E-56676CF1D680Q35571039-A207D806-2167-4483-92CE-BAC26918EADFQ36102155-3D37753E-2D2F-4128-BFF7-EC8331F5FA50Q36210067-8CF01CC5-0B85-4F2B-B238-8EE5EC0C5287Q36400580-F8502410-1021-4FBB-B595-E854494560E5Q36419349-D558AD98-AC4C-41D7-BB84-BF4A486E99EEQ36525799-EF1C184B-5E24-4ECE-B037-75CBF44C1946Q36567310-083EA6EC-9AEE-4D65-96E0-7048767B1950Q36573796-121D7555-A3E3-405F-A0FA-7EC7DC5CE834Q36672863-0CBE98A1-3ECB-4BDF-8D7D-2F9952222892Q37147923-3C3407A5-1C8B-4539-AB8F-DFE73B7287DBQ37157600-192002BC-E1BE-4758-BD16-EE2F155D121BQ37221548-D142FFDF-DCD4-4566-880E-2798EBFA282BQ37577432-BCF1381F-F799-4895-A1E4-A7DD3465184BQ37637761-9FD1FD75-EBE6-4EF9-9C18-486EDDB0ACAFQ37900493-E7CD4223-8152-4EB9-80A6-A60C2465328EQ38162433-85A9F425-6274-4F83-B09E-4C94A8D1AB80Q38233855-823F8371-7D67-400E-927A-C92CFC11DAFEQ38546915-9C238F72-329A-4C5E-9605-0850BF1B6DB7Q38970979-7C595DF0-CAF3-453B-B623-48A7E81CFF16Q39727387-1C52AFE1-21F5-4CC9-B0A5-AB0F8FEF6941Q40042284-70AAF5D4-64E6-4ACC-BCD3-8D44ED816F15Q40979686-A9E1773A-B389-4A04-80B6-A308370CC793Q41810246-4967359A-3E56-406B-9C93-4FFDD8D7BE5FQ43102831-65A2BA29-F500-47EF-8D1B-07EDDF4D71D0Q46116440-6BAADBFE-4690-4EA6-A7A5-F1022006805AQ49330579-91A9CEC5-526F-4B3F-AA31-6345DF3BE50CQ55519675-2E0B50A7-7D1F-42C6-AC7B-FF284B5162BCQ56113559-546C107A-5C51-47EA-99DE-EC69915F2974Q58907881-DB988F86-FCF0-4C3F-97E0-4E333C4536D1
P2860
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@ast
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@en
type
label
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@ast
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@en
prefLabel
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@ast
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@en
P2093
P921
P356
P1433
P1476
Nepafenac, a unique nonsteroid ...... of anti-inflammatory efficacy.
@en
P2093
P2888
P304
P356
10.1023/A:1007049015148
P577
2000-08-01T00:00:00Z
P6179
1052497400